AJP - Heart BIOPAC complete lab solutions
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (May 13, 2005). doi:10.1152/ajpheart.00251.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/3/H1191    most recent
00251.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sampei, K.
Right arrow Articles by Koehler, R. C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sampei, K.
Right arrow Articles by Koehler, R. C
Submitted on March 15, 2005
Accepted on May 6, 2005

Role of Nitric Oxide Scavenging in Vascular Response to Cell-Free Hemoglobin Transfusion

Kenji Sampei1, John A Ulatowski1, Yoshio Asano1, Herman Kwansa1, Enrico Bucci2, and Raymond C Koehler1*

1 Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins University, Baltimore, Maryland, USA
2 Department of Biochemistry and Molecular Biology, University of Maryland, Baltimore, Maryland, USA

* To whom correspondence should be addressed. E-mail: rkoehler{at}jhmi.edu.

Modified hemoglobin (Hb) solutions have been developed as O2 carrier transfusion fluids, but of concern is the possibility that increased scavenging of nitric oxide (NO) within the plasma will alter vascular reactivity even if the Hb does not readily extravasate. The effect of decreasing hematocrit from approximately 30% to 18% by an exchange transfusion of a 6% sebacyl cross-linked tetrameric Hb solution on the diameter of pial arterioles possessing tight endothelial junctions was examined through a cranial window in anesthetized cats with and without a NO synthase (NOS) inhibitor. Superfusion of a NOS inhibitor decreased diameter, and subsequent Hb transfusion produced additional constriction that was not different from Hb transfusion alone, but was different from the dilation observed by exchange transfusion of an albumin solution after NOS inhibition. In contrast, abluminal application of the cross-linked Hb produced constriction that was attenuated by the NOS inhibitor. Neither abluminal nor intraluminal cross-linked Hb interfered with pial arteriolar dilation to cromakalim, an activator of ATP-sensitive potassium channels. Pial vascular reactivity to hypocapnia and hypercapnia was unaffected by Hb transfusion. Microsphere-determined regional blood flow indicated selective decreases in perfusion after Hb transfusion in kidney, small intestine, and neurohypohysis, which does not have tight endothelial junctions. Administration of a NOS inhibitor to reduce the basal level of NO available for scavenging prior to Hb transfusion prevented further decreases in blood flow to these regions compared to NOS inhibition alone. In contrast, blood flow to skeletal and left ventricular muscle increased and cerebral blood flow was unchanged after Hb transfusion. This cross-linked Hb tetramer is known to appear in renal lymph but not in urine. We conclude that cell-free tetrameric Hb does not scavenge sufficient NO in the plasma space to significantly affect baseline tone in vascular beds with tight endothelial junctions, but does produce substantial constriction in beds with porous endothelium. The data support increasing the molecular size of Hb by polymerization or conjugation to limit extravasation in all vascular beds in order to preserve normal vascular reactivity.




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Cao, L.-C. Wang, H. Kwansa, R. J. Roman, D. R. Harder, and R. C. Koehler
Endothelin rather than 20-HETE contributes to loss of pial arteriolar dilation during focal cerebral ischemia with and without polymeric hemoglobin transfusion
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2009; 296(5): R1412 - R1418.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. Mito, M. Nemoto, H. Kwansa, K. Sampei, M. Habeeb, S. J. Murphy, E. Bucci, and R. C. Koehler
Decreased Damage From Transient Focal Cerebral Ischemia by Transfusion of Zero-Link Hemoglobin Polymers in Mouse
Stroke, January 1, 2009; 40(1): 278 - 284.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. G. Tsai, P. Cabrales, B. N. Manjula, S. A. Acharya, R. M. Winslow, and M. Intaglietta
Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers
Blood, November 15, 2006; 108(10): 3603 - 3610.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Nemoto, T. Mito, W. S Brinigar, C. Fronticelli, and R. C. Koehler
Salvage of focal cerebral ischemic damage by transfusion of high O2-affinity recombinant hemoglobin polymers in mouse
J Appl Physiol, May 1, 2006; 100(5): 1688 - 1691.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Rebel, S. Cao, H. Kwansa, S. Dore, E. Bucci, and R. C. Koehler
Dependence of acetylcholine and ADP dilation of pial arterioles on heme oxygenase after transfusion of cell-free polymeric hemoglobin
Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1027 - H1037.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
X. Qin, H. Kwansa, E. Bucci, R. J. Roman, and R. C. Koehler
Role of 20-HETE in the pial arteriolar constrictor response to decreased hematocrit after exchange transfusion of cell-free polymeric hemoglobin
J Appl Physiol, January 1, 2006; 100(1): 336 - 342.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.